{
    "organizations": [],
    "uuid": "df4d545c5b2e51bc8cdcf7e6ec09ecbcaf3f973c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-minapharm-appoints-fincorp-as-fina/brief-minapharm-appoints-fincorp-as-financial-adviser-idUSFWN1RE00H",
    "ord_in_thread": 0,
    "title": "BRIEF-Minapharm Appoints Fincorp As Financial Adviser‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 1 (Reuters) - MINAPHARM PHARMACEUTICALS:\n* APPOINTS FINCORP AS INDEPENDENT FINANCIAL ADVISER TO STUDY FAIR VALUE OF MINA PHARM PROBIOGEN ‍​\n* INTENDS TO ACQUIRE 15.78 PERCENT ENTIRE STAKE OF TRIQUERA BV IN MINA PHARM PROBIOGEN Source:( bit.ly/2GHtkc2 ) Further company coverage:\n ",
    "published": "2018-04-01T16:42:00.000+03:00",
    "crawled": "2018-04-02T20:44:47.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "minapharm",
        "pharmaceutical",
        "appoints",
        "fincorp",
        "independent",
        "financial",
        "adviser",
        "study",
        "fair",
        "value",
        "mina",
        "pharm",
        "probiogen",
        "intends",
        "acquire",
        "percent",
        "entire",
        "stake",
        "triquera",
        "bv",
        "mina",
        "pharm",
        "probiogen",
        "source",
        "company",
        "coverage"
    ]
}